Many Putative Endocrine Disruptors Inhibit Prostaglandin Synthesis | Zendy

David M. Kristensen | Zendy; Maria Lena Skalkam | Zendy; Karine Audouze | Zendy; Laurianne Lesné | Zendy; Christèle Lethimonier | Zendy; Hanne Frederiksen | Zendy; Søren Brunak | Zendy; Niels E. Skakkebæk | Zendy; Bernard Jégou | Zendy; Jacob B. Hansen | Zendy; Steffen Junker | Zendy; Henrik Leffers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Many Putative Endocrine Disruptors Inhibit Prostaglandin Synthesis

Author(s) -

David M. Kristensen,

Maria Lena Skalkam,

Karine Audouze,

Laurianne Lesné,

Christèle Lethimonier,

Hanne Frederiksen,

Søren Brunak,

Niels E. Skakkebæk,

Bernard Jégou,

Jacob B. Hansen,

Steffen Junker,

Henrik Leffers

Publication year - 2010

Publication title -

environmental health perspectives

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.257

H-Index - 282

eISSN - 1552-9924

pISSN - 0091-6765

DOI - 10.1289/ehp.1002635

Subject(s) - receptor , endocrine system , prostaglandin , enzyme , chemistry , signal transduction , nuclear receptor , in vivo , lipid signaling , hormone , biology , biochemistry , pharmacology , transcription factor , gene , microbiology and biotechnology

Prostaglandins (PGs) play key roles in development and maintenance of homeostasis of the adult body. Despite these important roles, it remains unclear whether the PG pathway is a target for endocrine disruption. However, several known endocrine-disrupting compounds (EDCs) share a high degree of structural similarity with mild analgesics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research